Company Filing History:
Years Active: 2012
Title: Innovative Contributions of Zoltán Horváth in Pharmaceutical Chemistry
Introduction
Zoltán Horváth, an inventive mind based in Rácalmás, Hungary, has made a significant mark in the field of pharmaceutical chemistry with his innovative contributions. As an inventor, he has successfully secured one patent which reflects his dedication to advancing scientific knowledge and practical applications in medicine.
Latest Patents
Horváth's patent, titled "Industrial method for the synthesis of 17-acetoxy-11β-[4-(dimethylamino)-phenyl]-21-methoxy-19-norpregna-4,9-dien-3,20-dione and the key intermediates of the process," focuses on a novel synthesis process. This invention pertains to the transformation of specific chemical compounds, particularly detailing how 17-acetoxy-11β-[4-(dimethylamino)-phenyl]-21-methoxy-19-norpregna-4,9-dien-3,20-dione can be synthesized from another complex compound, showcasing the intricate methods employed in pharmaceutical developments.
Career Highlights
Zoltán Horváth is currently affiliated with Richter Gedeon Nyrt., a prominent pharmaceutical company known for its innovative research and development. His work within this esteemed organization highlights his commitment to advancing healthcare through innovative solutions and therapies. The experience and knowledge gained during his tenure significantly contribute to his expertise in the field.
Collaborations
Throughout his career, Horváth has collaborated with renowned colleagues, including József Bódi and György Visky. These partnerships are not only instrumental in the creation of new ideas but also in refining methodologies that enhance the efficiency and effectiveness of pharmaceutical processes.
Conclusion
Zoltán Horváth represents a pivotal figure in the landscape of pharmaceutical innovation. His patent showcases his ability to contribute novel solutions that may have a lasting impact on medical advancements. As research continues to evolve, the work of inventors like Horváth is crucial for shaping the future of healthcare and pharmaceutical science.